共 472 条
[1]
Reynolds MR(2008)Macaques vaccinated with live-attenuated SIV control replication of heterologous virus J Exp Med 205 2537-2550
[2]
Weiler AM(2009)Immune control of an SIV challenge by a T-cell-based vaccine in rhesus monkeys Nature 457 87-91
[3]
Weisgrau KL(2008)Improving defences at the portal of HIV entry: mucosal and innate immunity PLoS Med 5 e81-665
[4]
Piaskowski SM(2005)Placebo-controlled phase 3 trial of a recombinant glycoprotein 120 vaccine to prevent HIV-1 infection J Infect Dis 191 654-1671
[5]
Furlott JR(2006)Randomized, double-blind, placebo-controlled efficacy trial of a bivalent recombinant glycoprotein 120 HIV-1 vaccine among injection drug users in Bangkok, Thailand J Infect Dis 194 1661-236
[6]
Weinfurter JT(2004)HIV vaccine design and the neutralizing antibody problem Nat Immunol 5 233-294
[7]
Kaizu M(2007)Antibodies to HIV-1: aiming at the right target Trends Microbiol 15 291-578
[8]
Soma T(2009)HIV-1 and influenza antibodies: seeing antigens in new ways Nat Immunol 10 573-367
[9]
Leon EJ(1997)HIV-1 antibody--debris or virion? Nat Med 3 366-66
[10]
MacNair C(2010)Rational antibody-based HIV-1 vaccine design: current approaches and future directions Curr Opin Immunol 22 358-643